CureforU: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CureforU
Largest movements
- Cash -€5,169
down €5,169 (-97.3%), from €5,314 to €145
mainly Net result for the year (-€4,892) and Accrued charges and deferred income (-€3,000)
- Profit (loss) carried forward -€4,892
down €4,892, from €315 to -€4,577
- Accrued charges and deferred income -€3,000
down €3,000 (-100.0%), from €3,000 to €0
- Other debts +€2,900
new in 2025: €2,900
- Trade debts -€162
down €162 (-17.6%), from €920 to €758
- Gross operating margin -€5,182
down €5,182, from €498 to -€4,684
- Taxes -€64
down €64 (-100.0%), from €64 to €0
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €5,314 | €145 | -€5,169 | -97.3% |
| Current assets | 29/58 | €5,314 | €145 | -€5,169 | -97.3% |
| Cash at bank and in hand | 54/58 | €5,314 | €145 | -€5,169 | -97.3% |
| Total equity and liabilities | 10/49 | €5,314 | €145 | -€5,169 | -97.3% |
| Equity | 10/15 | €1,315 | -€3,577 | -€4,892 | |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €315 | -€4,577 | -€4,892 | |
| Amounts payable | 17/49 | €3,999 | €3,722 | -€277 | -6.9% |
| Amounts payable within one year | 42/48 | €999 | €3,722 | +€2,723 | +272.7% |
| Trade debts | 44 | €920 | €758 | -€162 | -17.6% |
| Suppliers | 440/4 | €920 | €758 | -€162 | -17.6% |
| Taxes, remuneration and social security | 45 | €79 | €64 | -€15 | -18.6% |
| Taxes | 450/3 | €79 | €64 | -€15 | -18.6% |
| Other amounts payable | 47/48 | - | €2,900 | +€2,900 | |
| Accrued charges and deferred income | 492/3 | €3,000 | €0 | -€3,000 | -100.0% |
| Gross operating margin | 9900 | €498 | -€4,684 | -€5,182 | |
| Operating profit (loss) | 9901 | €498 | -€4,684 | -€5,182 | |
| Financial charges | 65/66B | €178 | €207 | +€30 | +16.7% |
| Recurring financial charges | 65 | €178 | €207 | +€30 | +16.7% |
| Profit (loss) for the period before taxes | 9903 | €320 | -€4,892 | -€5,212 | |
| Income taxes | 67/77 | €64 | €0 | -€64 | -100.0% |
| Profit (loss) for the period | 9904 | €256 | -€4,892 | -€5,148 | |
| Profit (loss) for the period to be appropriated | 9905 | €256 | -€4,892 | -€5,148 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.